Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Enrollment status was updated to no longer recruiting participants. New navigation items such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.6%
    Check dated 2026-06-12T16:43:18.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor patch to the ClinicalTrials.gov page with potential small fixes or improvements without changing the study details.
    Difference
    0.1%
    Check dated 2026-06-05T12:39:52.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor platform/template update to the page. No changes to study data or content are introduced.
    Difference
    0.1%
    Check dated 2026-05-14T23:23:33.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.3, was added and the previous revision tag, v3.5.2, was removed. This reflects a metadata update to the page rather than a change to study content or results.
    Difference
    0.1%
    Check dated 2026-04-30T17:19:03.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown in the page footer, replacing Revision: v3.5.0. No changes to study content or data are indicated.
    Difference
    0.1%
    Check dated 2026-04-16T11:09:55.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and a Resources entry for Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T05:35:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.